Seeking Alpha

Shares of MAP Pharmaceuticals (MAPP -5.3%) slide today after the company priced its secondary...

Shares of MAP Pharmaceuticals (MAPP -5.3%) slide today after the company priced its secondary offering of 3.88M shares at $13.40, a 5% discount to yesterday's close. The company intends to use the proceeds to bring its investigational migraine drug Levadex to market, as well as for other general corporate purposes.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector